Dr. Ghulam Jilany Khan
Associate Professor
Ext: 251
Dr. Ghulam Jilany Khan has strong ambitions to serve the academia using all the knowledge and skills in academics via both theoretical and practical approach. He is very much determined to bring novel health care findings and ideas at practical and clinical level to enhance the health and educational standards of Pakistan. Presently he is working as Associate Professor of Pharmacology with core responsibilities to teach the subject of Pharmacology and Clinical Pharmacy to the students of Pharm. D and M. Phil as full time regular faculty member of University of Central Punjab and HEC approved Ph. D supervisor in the field of Medical Sciences. Being proficient in health care marketing, he also teaches a full module of pharmaceutical marketing to outgoing final year batch of Pharm. D. Besides the academics, based on his technical and administrative capabilities, he is also serving as focal person of Pharm. D admission committee; Coordinator of Curricula review committee; core focal person for Pharm. D accreditation and renewal with Pharmacy Council of Pakistan (PCP) and other governing bodies; head incharge of Pharmacology section at FOP, UCP. Dr. Khan is devotedly involved in multiple research projects and has more than 65 scientific publication to his credit. His total impact factors is more than 180 with h-index of 19, i-10 index of 33 and more than 1750 citations/mentions (academia.edu). In addition to that he has also served as the editor of “Journal of international medical research” (impact factor: 1.32), editorial board member of many international journals as well as the Web of Science/Pubmed central database (Publon) verified reviewer of several research journals where he is ranked within top 5 percentile all over the globe in the field of Pharmacology since beginning and among top 1% within year 2019-2021 (Publon/web of science database).
| Post Doctorate | Biological Sciences and Medical Engineering | South East University, Nanjing | 2024 |
| PGD | Clinical Pharmacy (Pharmacology) | Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Canada | 2017 |
| Ph. D | Pharmacology | School of Pharmacy, China Pharmaceutical University, Nanjing, P. R. China | 2014-2017 |
| M. Phil | Pharmacology and Toxicology | University of Veterinary and Animal Sciences, Lahore, Pakistan | 2010-2012 |
| MBA | Healthcare Marketing | University of Veterinary and Animal Sciences, Lahore, Pakistan | 2008-2010 |
| Pharm. D | Pharmacy (Degree Upgradation) | University college of Pharmacy, University of The Punjab, Lahore, Pakistan | 2007-2008 |
| B. Pharmacy | Pharmacy | University college of Pharmacy, University of The Punjab, Lahore, Pakistan | 2006 |
| Associate Professor of Pharmacology (Section in-charge) | Faculty of Pharmacy, University of Central Punjab, Lahore, Pakistan | 2020 till date |
| Assistant Professor | Faculty of Pharmacy, University of Central Punjab, Lahore, Pakistan | 2018-2020 |
| Lecturer | Faculty of Pharmacy, University of Central Punjab, Lahore, Pakistan | 2013-2018 |
| Pharmacy Manager | New Mehmood Pharmacy | 2012-2013 |
| Lecturer/Campus Coordinator | AIHS, UHS Lahore | 2010-2012 |
| Chief Pharmacist | CPMC teaching Hospital, Kasur | 2009-2010 |
| Branch Pharmacist/Shift In-charge | Fazal Din’s Pharma Plus, Lahore | 2007-2009 |
Click to View
1. Extracellular vesicle-derived miR-146a as a novel crosstalk mechanism for high-fat induced atherosclerosis by targeting SMAD4. Journal of Advanced Research. I.F. 11.4
2. Thymus as incontrovertible target of immune modulatory future therapeutics. Endocrine, Metabolic & Immune Disorders – Drug Targets. I.F. 2.0
3. Ginsenoside Rg1 ameliorates blood brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release. Acta Pharmaceutica Sinica B. I.F. 14.903.
4. Exploring the molecular mechanism of Artemisia rupestris L. for the treatment of hepatocellular carcinoma via PI3K/AKT pathway. Journal of Ethnopharmacology. I.F. 5.4
5. Targeted intervention of natural medicinal active ingredients and traditional Chinese medicine on epigenetic modification: possible strategies for prevention and treatment of atherosclerosis. Phytomedicine. I.F. 7.91
6. Non-Muscle Myosin IIC as a Prognostic and Therapeutic Target in Cancer. Journal of Biomedical Nanotechnology. I.F. 3.641
7. Determination of Anti-oxidative stress mechanism of Isodon suzhouensis leaves by employing bioinformatic and traditional research tools. ACS Omega. I.F. 4.132
8. Effects of Curcuma Longa L. and Piper Nigrum L. against Methicillin resistant Staphylococcus Aureus and infectious angiogenesis. Journal of Biobased Materials and Bioenergy. I.F. 1.126
9. The potential mechanism of Isodon suzhouensis against COVID-19 via EGFR/TLR4 Pathway. Food Science and Human Wellness. I.F. 8.022
10. Design of a Novel Integrated Microfluidic Chip for Continuous Separation of Circulating Tumor Cells from Peripheral Blood Cells Nature (S.R). I.F. 4.996
11. Total flavonoid extract from Dracocephalum moldavica L. improve pulmonary fibrosis by reducing inflammation and inhibiting the Hedgehog signaling pathway. Phytotherapy research. I.F. 6.388
12. Identification of phytochemicals and antioxidant activity of Premna microphylla Turcz. stem through UPLC-LTQ-Orbitrap-MS. Food Chemistry. I.F. 9.231
13. Computational pharmacology and bioinformatics to explore the potential mechanism of Schisandra against atherosclerosis. Food and Chemical Toxicology. I.F. 5.572
14. Identification and characterization of potential antioxidant components in Isodon amethystoides (Benth.) Hara tea leaves by UPLC-LTQ-Orbitrap-MS. Food and Chemical Toxicology. I.F. 5.572
15. The integrin facilitated internalization of fibronectin-functionalized camptothecin-loaded DNA-nanofibers for high-efficiency anticancer effects. Drug Delivery and Translational Research. I.F. 5.671
16. DT-13 inhibits breast cancer cell migration via non-muscle myosin II-A regulation in tumor microenvironment synchronized adaptations. Clinical And Translational Oncology. I.F. 3.405
17. Synthetic NRG-1 Functionalized DNA Nanospindels Towards HER2/neu Targets for in Vitro Anti-Cancer Activity Assessment Against Breast Cancer MCF-7 Cells. Journal of Pharmaceutical and Biomedical Analysis. I.F. 3.935
18. In-vitro pre-treatment of cancer cells with TGF-β1: A novel approach of tail vein lung cancer metastasis mouse model for anti-metastatic studies. Current Molecular Pharmacology. I.F. 3.339
19. Protective effects of Isodon Suzhouensis extract and glaucocalyxin A on chronic obstructive pulmonary disease through SOCS3-JAKs/STATs pathway. Food Frontiers. I.F. 9.9
20. DNA scaffold nanoparticles coated with HPMC/EC for oral delivery. International journal of pharmaceutics. I.F. 6.510
21. Revealing synergistic mechanism of multiple components in compound Fengshiding capsule for rheumatoid arthritis therapeutics by network pharmacology. Current Molecular medicine. I.F. 3.084
22. Design, synthesis and evaluation of DNA nano-cubes as a core material protected by the alginate coating for oral administration of anti-diabetic drug. Journal of food and drug analysis. I.F. 6.079
23. Chitosan-coated rectangular DNA nanospheres for better outcomes of anti-diabetic drug. Journal of nanoparticle research. I.F. 2.533
24. Evaluation of chitosan/eudragit hybrid coating over cubic DNA nanospheres with superior stability and therapeutic outcomes. Journal of Drug Delivery Science and Technology. I.F. 3.981
25. PLL alginate and the HPMC EC hybrid coating over the 3D DNA nanocubes as compact nanoparticles for oral administration. Applied nanoscience. I.F. 4.604
26. Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases. Drug Discovery Today. I.F. 8.369
27. Current and future biomarkers in gastric cancer. Biomedicine & Pharmacotherapy. I.F. 7.419
28. Salicin from Alangium chinense ameliorates rheumatoid arthritis by modulating the Nrf2-HO-1-ROS pathways. Journal of Agriculture and Food Chemistry. I.F. 5.895
29. Clinical evaluation of carcinoembryonic and carbohydrate antigens as cancer biomarkers to monitor palliative chemotherapy in advanced stage gastric cancer. Current problems in cancer. I.F. 2.367
30. Chemical Constituents from Cimicifuga dahurica and their Anti-Proliferative Effects on MCF-7 Breast Cancer Cells. Molecules. I.F. 4.927
31. TGF-β1 Causes EMT by Regulating N Acetyl Glucosaminyl Transferases via Downregulation of Non Muscle Myosin II-A through JNK/P38/PI3K Pathway in Lung Cancer. Current Cancer Drug Targets. I.F. 3.428
32. Cardio-supportive devices (VRD & DCC device) and patches for advanced heart failure: A review, summary of state of the art and future directions. Biomedicine & Pharmacotherapy. I.F. 7.419
33. Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy. International Journal of Molecular Sciences. I.F. 6.208
34. Interdependent and independent multidimensional role of tumor microenvironment on hepatocellular carcinoma. Cytokine. I.F. 3.926
35. Versatility of Cancer Associated Fibroblasts: Commendable Targets for Anti-Tumor Therapy. Current Drug Targets. I.F. 3.465
36. Vildagliptin loaded DNA origami nanospheres coated with Eudragit for oral delivery and better glycemic control in type 2 Diabetes mellitus. Biomedicine & Pharmacotherapy. I.F. 7.419
37. Apoptosis effects of Imperatorin on synoviocytes in rheumatoid arthritis through mitochondrial/caspase-mediated pathways. Food and Function. I.F. 6.375
38. Pharmacological effects and potential therapeutic targets of DT-13. Biomedicine & Pharmacotherapy. I.F. 7.419
39. Chlorogenic acid (CGA) A pharmacological review and call for further research. Biomedicine & Pharmacotherapy. I.F. 7.419
40. IDH mutations associated impact on related cancer epidemiology and subsequent effect toward HIF-1α. Biomedicine & Pharmacotherapy. I.F. 7.419
41. DT-13 attenuates human lung cancer metastasis via regulating NMIIA activity under hypoxia condition. Oncology Reports. I.F. 4.136
42. DT-13, a saponin monomer of dwarf lilyturf tuber, induces autophagy and potentiates anti-cancer effect of nutrient deprivation. European journal of pharmacology. I.F. 5.195
43. DT-13 inhibits cancer cell migration by regulating NMIIA indirectly in the tumor microenvironment. Oncology reports. I.F. 4.136
44. Effect of Marsdenia tenacissima extract on G2/M cell cycle arrest by upregulating 14-3-3σ and downregulating c-myc in vitro and in vivo. Chinese Herbal Medicine. I.F. 2.81
45. Understanding and responsiveness level about cervical cancer and its avoidance among the young women of Pakistan. Asian pacific Journal of cancer prevention. I.F. 2.54